Prostate Clinical Trial
Official title:
The Effect of Virtual Reality Glasses Application on Pain, Anxiety, and Patient Satisfaction During a Transrectal Prostate Biopsy: A Randomized Controlled Trial
NCT number | NCT05509114 |
Other study ID # | Rumeysa |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 25, 2021 |
Est. completion date | July 27, 2022 |
Verified date | August 2022 |
Source | Ataturk University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study was conducted in a randomized controlled manner to determine the effect of applying virtual reality glasses during transrectal prostate biopsy on pain, anxiety and patient satisfaction.The study was completed with a total of 70 patients, 35 in the intervention group and 35 in the control group, for whom it was decided to perform sample transrectal prostate biopsy for the first time.
Status | Completed |
Enrollment | 70 |
Est. completion date | July 27, 2022 |
Est. primary completion date | June 20, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Those between the ages of 18-65, - Those who volunteer and accept to participate in the research, - Transrectal prostate biopsy procedure performed for the first time, - No communication problem, - Cognitive level scales are suitable for application, - Patients without vision or hearing problems were included in the study. Exclusion Criteria: - Leaving work voluntarily, - Patients whose cognitive level scales were not suitable for application were excluded from the study. |
Country | Name | City | State |
---|---|---|---|
Turkey | Rumeysa Lale TORAMAN | Palandöken | Erzurum |
Lead Sponsor | Collaborator |
---|---|
Ataturk University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | State-Trait Anxiety Inventory (STAI-I, STAI-II) | It is a test developed by Spielberger et al. that measures state and trait anxiety levels. Its validity and reliability in Turkey was done by O¨ner and Le Compte. The scale consists of two parts, the 'state anxiety scale', which is created with the aim of determining the instantaneous feelings, and the 20-item 'trait anxiety scale', which was created to determine the feelings in general. It is a four degree scale ranging from 'Nothing' to 'All'. Scores range from 20 (low anxiety) to 80 (high anxiety). | up to 24 hours | |
Primary | The Scale of Patient Perception of Hospital Experience with Nursing Care (PPHEN) | The patient's perception of nursing care scale was developed by Dozier et al. in the USA, and its Turkish validity and reliability were determined by Çoban and Kasikçi.Likert-type scale has 15 statements about the quality of nursing care. A minimum of 15 and a maximum of 75 points can be obtained from the scale. The cut-off point of the scale is 45. Scores above the cut-off point indicate a positive attitude. The increase in the total score obtained from the scale indicates that the patient is satisfied with the nursing care. | up to 24 hours | |
Primary | Visual Analog Scale for Pain (VAS) | VAS is a scale developed by Price et al34 (1983) and measures the severity of pain in the patient. VAS is a 10 cm long vertical or horizontal scale with two different names (0=no pain, 10=most severe pain). An increase in the score obtained from the scale in the evaluation indicates an increase in pain. | up to 24 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03197896 -
Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods
|
N/A | |
Completed |
NCT00026689 -
Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
|
||
Completed |
NCT00547625 -
Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems
|
Phase 2 | |
Completed |
NCT00648323 -
Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement
|
Phase 4 | |
Completed |
NCT00579423 -
Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer
|
Phase 2 | |
Completed |
NCT00342433 -
Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study
|
||
Active, not recruiting |
NCT03047135 -
Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis
|
Phase 2 | |
Enrolling by invitation |
NCT06364865 -
AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
|
||
Terminated |
NCT03197948 -
Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment
|
||
Completed |
NCT00586898 -
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
|
Phase 2 | |
Recruiting |
NCT04518072 -
Synthetic Metabolic and Genetic Networks for Medical Diagnosics
|
||
Completed |
NCT01118260 -
Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection
|
Phase 4 | |
Recruiting |
NCT00923221 -
Collection of Blood From Patients With Prostate Cancer
|
||
Active, not recruiting |
NCT01078662 -
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
|
Phase 2 | |
Completed |
NCT00423254 -
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.
|
Phase 1 | |
Terminated |
NCT02918227 -
Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia
|
N/A | |
Completed |
NCT02756975 -
Prostate Core Needle Biopsy
|
N/A | |
Active, not recruiting |
NCT00572468 -
Statin Therapy Versus Placebo Prior to Prostatectomy
|
N/A | |
Completed |
NCT00364455 -
Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer.
|
Phase 3 | |
Terminated |
NCT03318367 -
Virtual Reality Education Module in Reducing Anxiety and Increasing Knowledge in Patients With Prostate Cancer Undergoing Radiation Therapy
|
N/A |